Renaissance Technologies LLC Boosts Holdings in Exagen Inc. (NASDAQ:XGN)

Renaissance Technologies LLC boosted its stake in shares of Exagen Inc. (NASDAQ:XGN) by 93.3% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 94,234 shares of the company’s stock after purchasing an additional 45,476 shares during the period. Renaissance Technologies LLC owned approximately 0.54% of Exagen worth $172,000 at the end of the most recent quarter.

Exagen Trading Down 1.9 %

XGN stock opened at $2.65 on Monday. Exagen Inc. has a 52-week low of $1.30 and a 52-week high of $3.71. The company has a quick ratio of 4.32, a current ratio of 4.32 and a debt-to-equity ratio of 1.13. The firm has a market cap of $46.08 million, a P/E ratio of -2.73 and a beta of 1.32. The company’s 50-day simple moving average is $2.95 and its 200-day simple moving average is $2.18.

Exagen (NASDAQ:XGN) last released its earnings results on Monday, August 5th. The company reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.20. Exagen had a negative net margin of 30.56% and a negative return on equity of 78.90%. The business had revenue of $15.06 million during the quarter, compared to analysts’ expectations of $13.20 million. During the same quarter in the previous year, the company earned ($0.28) earnings per share. As a group, equities analysts forecast that Exagen Inc. will post -1.02 EPS for the current fiscal year.

Exagen Company Profile

Exagen Inc develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).